These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 106288)

  • 41. Methadone/LAAM maintenance: a comparison study.
    Savage C; Karp EG; Curran SF; Hanlon TE; McCabe OL
    Compr Psychiatry; 1976; 17(3):415-24. PubMed ID: 776522
    [No Abstract]   [Full Text] [Related]  

  • 42. LAAM--a long-acting methadone for treatment of heroin addiction.
    Med Lett Drugs Ther; 1994 Jun; 36(924):52. PubMed ID: 8196570
    [No Abstract]   [Full Text] [Related]  

  • 43. A clinical experience with LAAM.
    Goldstein A
    NIDA Res Monogr; 1976 Jul; (8):115-7. PubMed ID: 995176
    [No Abstract]   [Full Text] [Related]  

  • 44. Plasma testosterone and luteinizing hormone levels during levo-alpha-acetylmethadol maintenance and withdrawal.
    Mendelson JH; Ellingboe J; Judson BA; Goldstein A
    Clin Pharmacol Ther; 1984 Apr; 35(4):545-7. PubMed ID: 6705455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Restabilization with methadone after methadyl acetate maintenance.
    Ling W; Blakis M; Holmes ED; Klett CJ; Carter WE
    Arch Gen Psychiatry; 1980 Feb; 37(2):194-6. PubMed ID: 7352850
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Follow-up study of subjects on methadyl acetate and methadone.
    Charuvastra VC; Panell J; Ling W; Ouren J
    Drug Alcohol Depend; 1980 Nov; 6(5):273-84. PubMed ID: 7460760
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Levo-alpha-acetylmethadol (LAAM) for opiate addiction.
    Ling W
    Curr Psychiatr Ther; 1978; 18():173-80. PubMed ID: 380927
    [No Abstract]   [Full Text] [Related]  

  • 48. On the role of chemotherapy in the treatment of heroin addiction.
    Goldstein A
    Am J Drug Alcohol Abuse; 1975; 2(3-4):279-88. PubMed ID: 1227291
    [No Abstract]   [Full Text] [Related]  

  • 49. Success and failure of LAAM maintenance: selected case studies.
    Tyler J; Hargreaves WA; Weinberg JA
    J Psychedelic Drugs; 1980; 12(1):41-6. PubMed ID: 7392057
    [No Abstract]   [Full Text] [Related]  

  • 50. Episodes of heroin use during maintenance treatment with stable dosage of (-)-alpha-acetylmethadol (methadyl acetate, LAAM).
    Judson BA; Goldstein A
    Drug Alcohol Depend; 1983 Jun; 11(3-4):271-8. PubMed ID: 6617466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Withdrawal from heroin in three or six weeks. Comparison of methadyl acetate and methadone.
    Sorensen JL; Hargreaves WA; Weinberg JA
    Arch Gen Psychiatry; 1982 Feb; 39(2):167-71. PubMed ID: 7065831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The phase III clinical evaluation of LAAM: I. Comparative epidemiology of mortality in LAAM and methadone.
    Thomas DB; Whysner JA; Newmann MC
    NIDA Res Monogr; 1979; 27():289-295b. PubMed ID: 121344
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Failure of methadone and levomethadyl acetate (levo-alpha-acetylmethadol, LAAM) maintenance to affect memory.
    Grevert P; Masover B; Goldstein A
    Arch Gen Psychiatry; 1977 Jul; 34(7):849-53. PubMed ID: 879977
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Every-other-day acetylmethadol disturbs circadian cycles of human motility.
    Crowley TJ; Jones RH; Hydinger-Macdonald MJ; Lingle JR; Wagner JE; Egan DJ
    Psychopharmacology (Berl); 1979 Apr; 62(2):151-5. PubMed ID: 111279
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comments on Ritter et al.'s report of a comparative trial of LAAM and methadone maintenance.
    Caplehorn J
    Addiction; 2004 Apr; 99(4):509-10; author reply 510-1. PubMed ID: 15049750
    [No Abstract]   [Full Text] [Related]  

  • 56. Withdrawal from heroin in three or six weeks: comparison of LAAM versus methadone.
    Sorensen JL; Hargreaves WA; Weinberg JA
    NIDA Res Monogr; 1982 Apr; 41():230-1. PubMed ID: 6811913
    [No Abstract]   [Full Text] [Related]  

  • 57. Current status of the evaluation of LAAM as a maintenance drug for heroin addicts.
    Ling W; Charuvastra VC; Klett CJ
    Am J Drug Alcohol Abuse; 1975; 2(3-4):307-15. PubMed ID: 775968
    [No Abstract]   [Full Text] [Related]  

  • 58. Levo-alpha-acetylmethadol (LAAM): clinical, research, and policy issues of a new pharmacotherapy for opioid addiction.
    Prendergast ML; Grella C; Perry SM; Anglin MD
    J Psychoactive Drugs; 1995; 27(3):239-47. PubMed ID: 8594167
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of acetylmethadol on plasma testosterone.
    Mendelson JH; Inturrisi CE; Renault P; Senay EC
    Clin Pharmacol Ther; 1976 Mar; 19(3):371-4. PubMed ID: 1261171
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized trial comparing levo-alpha acetylmethadol with methadone maintenance for patients in primary care settings in Australia.
    Ritter AJ; Lintzeris N; Clark N; Kutin JJ; Bammer G; Panjari M
    Addiction; 2003 Nov; 98(11):1605-13. PubMed ID: 14616187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.